Kamezaki Hidehiro, Iwanaga Terunao, Maeda Takahiro, Senoo Junichi, Ogasawara Sadahisa, Kato Naoya
Department of Gastroenterology, Eastern Chiba Medical Center, Japan.
Department of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Intern Med. 2025 Mar 1;64(5):625-629. doi: 10.2169/internalmedicine.4092-24. Epub 2024 Jul 18.
Objective Abstaining from alcohol improves the outcome of alcohol-related cirrhosis. This study evaluated the effect of alcohol abstinence on the outcomes of patients with alcohol-related cirrhosis recruited from a core hospital in Boso Peninsula, Japan. Methods This single-center retrospective study recruited 116 patients with alcohol-related cirrhosis who were admitted to our department between April 2014 and October 2022. Taking the day of discharge as day 0, the patients were divided into two groups based on their subsequent behavior (abstinence/non-abstinence from alcohol). The study analysis included 98 patients after excluding 13 who died during hospitalization and 5 for whom follow-up at our hospital ended after discharge. We evaluated differences in the patient survival between the abstaining and drinking groups. Results The abstaining and drinking groups comprised 57 and 41 patients, respectively. We excluded from the analysis 10 and 6 patients with viable hepatocellular carcinoma in the abstaining and drinking groups, respectively. The findings revealed that the survival rate plateaued in the abstaining group from the third year onward, whereas the survival rate in the drinking group gradually decreased with time. Conclusion Our findings suggest that at least two years of alcohol abstinence is required to sustain the survival of patients with alcohol-related cirrhosis. The data collected by our hospital retrospectively demonstrated the importance of abstinence on a timescale of years of sustained abstinence.
目的 戒酒可改善酒精性肝硬化的预后。本研究评估了戒酒对从日本房总半岛一家核心医院招募的酒精性肝硬化患者预后的影响。方法 本单中心回顾性研究纳入了2014年4月至2022年10月期间入住我科的116例酒精性肝硬化患者。以出院日为第0天,根据患者随后的行为(戒酒/未戒酒)将其分为两组。在排除13例住院期间死亡的患者和5例出院后在我院随访结束的患者后,研究分析纳入了98例患者。我们评估了戒酒组和饮酒组患者生存率的差异。结果 戒酒组和饮酒组分别有57例和41例患者。我们分别从戒酒组和饮酒组的分析中排除了10例和6例有存活肝细胞癌的患者。结果显示,戒酒组从第三年起生存率趋于平稳,而饮酒组的生存率随时间逐渐下降。结论 我们的研究结果表明,酒精性肝硬化患者至少需要戒酒两年才能维持生存。我院回顾性收集的数据证明了在持续戒酒数年的时间尺度上戒酒的重要性。